This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Georgia Tech Research Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Bocheng Wu: Innovator in Glycosylated Histone Deacetylase Inhibitors
Introduction
Bocheng Wu is a prominent inventor based in Atlanta, GA (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of glycosylated compounds that serve as histone deacetylase inhibitors.
Latest Patents
Wu holds a patent for "Glycosylated histone deacetylase inhibitors and methods of making and using the same." This patent describes glycosylated compounds that act as histone deacetylase (HDACi) inhibitors, including their diastereomers, solvates, and pharmaceutically acceptable salts. The patent also outlines pharmaceutical compositions and medicaments that incorporate these compounds, along with methods for treating inflammatory diseases and cancer.
Career Highlights
Bocheng Wu is affiliated with the Georgia Tech Research Corporation, where he continues to advance research in his field. His work has garnered attention for its potential applications in treating serious health conditions.
Collaborations
Wu collaborates with Subhasish Tapadar, contributing to innovative research and development in their area of expertise.
Conclusion
Bocheng Wu's work in glycosylated histone deacetylase inhibitors represents a significant advancement in medicinal chemistry, with promising implications for the treatment of inflammatory diseases and cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile